This article has been updated to include comments from Sterigenics. Medical device sterilization plants in the Atlanta area have come under scrutiny from neighbors and state officials following the publication of an investigative report by Georgia Health News and WebMD. Ethylene oxide plants owned by Sterigenics in Atlanta and Becton Dickinson in Covington, Ga., reported […]
BD’s Bard pulls all pelvic mesh products from EU market
Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard is removing its women’s pelvic organ prolapse and stress urinary incontinence mesh devices from the European Market, according to a recently posted field corrective action from the company. The Murray Hill, N.J.-based company said that it is “initiating a cease in production and distribution of these devices and a […]
Bard wins surgical mesh case on appeal
C.R. Bard (NYSE:BCR) and subsidiary Davol have won their appeal in a lawsuit involving a woman who died a year after having a Bard surgical mesh patch implanted to repair a hernia. The three-judge panel of the U.S. Court of Appeals for the Southern District of Indiana (Seventh Circuit) found that the estate of Georgia […]
QT Vascular expands pivotal trial of Chocolate Touch DCB
QT Vascular said today that the FDA approved the company’s request to expand an on-going pivotal study of its Chocolate Touch drug-coated balloon to include the use of atherectomy for lesion preparation. The U.S. regulatory agency also approved the addition of subgroup analysis related to the use of atherectomy. Get the full story at our sister […]
BD’s Bard updates on higher restenosis rate for LifeStream covered iliac stent
C.R. Bard (NYSE:BCR) has notified buyers of its LifeStream covered iliac stent of a higher-than-anticipated restenosis rate among patients. The field notice issued by Bard, parent company BD and Irish catheter-maker ClearStream Technologies said the restenosis rate of 0.04% exceeds the acceptable failure rate of 0.01%. An unspecified number of restenosis complaints was reported following implantation of […]
BD’s Bard reported to win third IVC bellwether
A federal jury in Arizona reportedly found for Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard today in a bellwether product liability case brought over its inferior vena cava filters. Although it’s the fourth bellwether case in the multi-district litigation over the IVC devices, which are designed to prevent blood clots from passing through the body’s […]
Judge pares claims in Bard IVC bellwether
A federal judge in Arizona yesterday pared some claims in the third bellwether case involving inferior vena cava filters made by Becton Dickinson (NYSE:BDX) subsidiary C.R. Bard, as the trial entered its 11th day. It’s the fourth bellwether in the multi-district litigation over the IVC devices, which are designed to prevent blood clots from passing through […]
Appeals court overturns patent board in Bard spat with AngioDynamics
A federal court this week reversed a number of Patent Trial and Appeal Board rulings which invalidated patents held by Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard in an ongoing patent spat with AngioDynamics (NSDQ:ANGO) . The case involves three C.R. Bard medical device patents, which in previous proceedings had had 34 of 41 claims invalidated as anticipated […]
Missouri appeals court revives pelvic mesh suit against BD’s Bard
A Missouri state appeals court last week revived a pelvic mesh product liability lawsuit against Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard, ruling that a lower court was wrong to exclude prior verdicts that went against the company. Barad and co-defendant Boston Scientific (NYSE:BSX) escaped the suit in February 2016 after a Kansas City jury voted 10-2 […]
AngioDynamics nets a win in antitrust case against BD’s Bard
A federal judge in New York this week denied a motion from Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard to dismiss an antitrust lawsuit filed by AngioDynamics (NSDQ:ANGO) alleging unfair competition, according to an Albany Business Review report. AngioDynamics filed the suit against Bard last May, claiming that the larger company illegally ties the sales of its […]
Hologic CFO McMahon jumps ship to Agilent | Personnel Moves – August 1, 2018
Hologic (NSDQ:HOLX) said yesterday that its CFO Bob McMahon is leaving to take up a CFO role at Agilent Technologies. The Marlborough, Mass.-based company said that its current chief accounting officer Karleen Oberton has been lifted to CFO, effective today. “Bob has made tremendous contributions to Hologic over the last four years, and we wish him […]
- 1
- 2
- 3
- …
- 30
- Next Page »
